ipscell.com
Parkinson's IPS cell trial in Japan switching to allogeneic - The Niche
What's better for stem cell trials such as for vision loss or Parkinson's Disease: allogeneic or autologous cells? It seems to depend.
Professor Paul Knoepfler, Ph.D.
